TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/13/23 17:09 | 3/3/23 | LHDX | Lucira Health, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Collins Kevin Walter | CA | O | Chief Re | S.m | -74 | 0.6604 | 0 | -112 | -32 | 235 | D | ||||||||||||||
11/29/22 12:08 | 11/27/22 | LHDX | Lucira Health, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Collins Kevin Walter | CA | O | Chief Re | S | -4 | 0.4200 | 0 | -10 | -3 | 347 | D | ||||||||||||||
8/29/22 20:22 | 8/27/22 | LHDX | Lucira Health, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Collins Kevin Walter | CA | O | Chief Re | S | -15 | 1.72 | 0 | -9 | -2 | 356 | D | ||||||||||||||
7/12/22 18:24 | 5/27/22 | LHDX | Lucira Health, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Collins Kevin Walter | CA | O | Chief Re | S | -74 | 2.00 | 0 | -37 | -9 | 365 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |